Pharmacokinetics Services Market Size, Share & Trends Report

Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules, Large Molecules (Biopharmaceuticals)), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

  • Published Date: May, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-375-1
  • Format: Electronic (PDF)
  • Historical Data: 2013 - 2017
  • Number of Pages: 100

Industry Insights

The global pharmacokinetics services market size was valued at USD 652.8 million in 2017 and is projected to expand at a CAGR of 8.3% during the forecast period.Poor pharmacokinetics (PK) of therapeutics is one of the key reasons for higher drug attrition. In order to reduce concerns about high drug attrition, researchers are embracing the trend of PK investigation of novel moieties at each development stage.

U.K. pharmacokinetics services market

Furthermore, implementation of predictive preclinical pharmacokinetics/ pharmacodynamics (PK/PD) models in various stages of clinical trials is recognized as a promising way to address major bottlenecks in the pharmaceutical development process. This is primarily because PK studies enable early identification of potential challenges and thereby assist in required modifications and other development strategies to mitigate drug development challenges.

Over the past decades, PK has gained significant prominence in drug discovery. Having understood the role of pharmacokinetics in pharmaceutical development, government and regulatory bodies are undertaking focused efforts to standardize pharmacokinetic protocols.

In the past years, regulatory requirements for clinical pharmacokinetic data have been progressively evolving in order to address safety implications of the drug candidate. This factor has played a vital role in reshaping this market.

PK/PD analysis has helped in progressing drug development from preclinical studies to rapid and efficient in-man studies. Use of human in vivo as well as in vitro models for studying pharmacokinetics variability in the clinical development phase has been demonstrated for various pharmaceuticals.

Gradual evolution of drug development into sound pharmacology has prompted several companies to broaden their service portfolio to maintain their competitive edge in the market. This is evident through presence of a large number of companies with a broad service portfolio to serve various pharmaceutical development phases.

Moreover, PK studies are interfacing other drug discovery functions, such as toxicology, clinical pharmacology, and marketing. This, in turn, has lucratively bolstered the adoption of PK services within the pharmaceutical industry.

Certain limitations pertaining to in vitro PK studies, such as inability of available experiments and protocols to predict complete interactions of target and drug candidate, are expected to hamper market growth during the forecast period.

Drug Type Insights

With respect to services offered as per drug type, the market is bifurcated into small and large (biopharmaceuticals) molecules. Small-molecule pharmacokinetic services emphasize on studying molecules of smaller atomic weight and drug metabolism and amount of drug compound in urine, blood, saliva, and tissue, using chromatographic techniques in combination with spectroscopic assays.

Large-molecule pharmacokinetic techniques include measurement of proteins, peptide interactions, and mostly greater weight molecules, such as IgE antibodies. They also include immunogenicity assays, Electrochemiluminescence (ECL) assays, and vaccine potency support as well as various other assays like ELISA.

With respect to revenue generation in 2017, PK analysis for small molecules accounted for the largest share owing to high market penetration. This segment is expected to expand at a lucrative pace owing to the growing market for generics.

Global pharmacokinetics services market

Although PK analysis for large molecules is estimated to hold a relatively smaller share in the pharmacokinetics services market in comparison to small molecules, this segment is anticipated to grow at a faster rate. This is majorly due to rising demand for biologics and biosimilars, which has prompted CROs to invest in broadening their PK analysis service portfolio for large moieties.

Regional Insights

North America accounted for the largest revenue share in 2017 owing to presence of a large number prominent pharmaceutical companies in the region. A number of strategic alliances have been observed between major U.S.-based drug manufacturers and CROs that offer PK investigation services in the region. Presence of effective regulatory structure pertaining to drug development processes including PKPD and toxicology studies in the region is one of the crucial factors enabling North America’s dominance.

Asia Pacific is estimated to be the fastest growing regional market owing to perpetual business expansion of CROs in this region. Asian countries offer low operating and manufacturing costs in comparison to developed economies. Moreover, there is a strong presence of potential subject bodies in Asia Pacific. These two factors are expected to serve as driving factors for the growth of pharmacokinetic services in Asian economies.

Pharmacokinetics Services Market Share Insights

Some of the key service providers in the market are Evotec AG;Certara, L.P.; Pacific BioLabs; GVK Biosciences Private Limited; Shanghai Medicilon Inc.; Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; Eurofins Scientific, Inc.; Frontage Labs; SGS SA; LGC Limited; and Creative Bioarray.

These service providers are engaged in mutually beneficial partnerships with several prominent pharmaceutical and biopharmaceutical companies across the globe. Furthermore, these service providers are making focused efforts to meet demands of pharmaceutical developers and enhance their market position.

Report Scope



Base year for estimation


Actual estimates/Historical data

2013 - 2017

Forecast period

2018 - 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, Germany, U.K., Japan, China, India, Brazil, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2013 to 2025. For the purpose of this report, Grand View Research has segmented the global pharmacokinetics services market report on the basis of drug type and region:

  • Drug Type Outlook (Revenue, USD Million, 2013 - 2025)

    • Small Molecules Pharmacokinetics Services

    • Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

  • Regional Outlook (Revenue, USD Million, 2013 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified